Mohammed Farrag El-Behairy (Mohammed F El-Behairy)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Molecular Docking

Photodynamic Therapy

Capillary Electrophoresis

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem (2024)
Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem 19 (10) (2024)
Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem 19 (10) (2024)
Eman M Alghamdi, Zahra M Alamshany, Mohamed A El Hamd, Ehab S Taher, Mohammed Farrag El-Behairy, Philip L Norcott, Adel A Marzouk
Anticancer Activities of Tetrasubstituted Imidazole-Pyrimidine-Sulfonamide Hybrids as Inhibitors of EGFR Mutants. ChemMedChem (2023)
Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Mohamed M Khalifa, Mohamed S Nafie, Mohamed A Saleh, Mohammed S Abdel-Maksoud, Tarfah Al-Warhi, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Mohamed M Khalifa, Mohamed S Nafie, Mohamed A Saleh, Mohammed S Abdel-Maksoud, Tarfah Al-Warhi, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Samar A El-Kalyoubi, Ehab S Taher, Tarek S Ibrahim, Mohammed Farrag El-Behairy, Amany M M Al-Mahmoudy
Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline-Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Ahmed H Tantawy, Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Hong Jiang, Man-Qun Wang, Adel A Marzouk
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Fluorinated Candidates as PI3K Inhibitors: Targeting Fluorophilic Binding Sites. Journal of medicinal chemistry 64 (23) (2021)
Mohammed Farrag El-Behairy, Rasha M Hassan, Inas A Abdallah
Enantioselective Separation of Chiral N1-Substituted-1H-pyrazoles: Greenness Profile Assessment and Chiral Recognition Analysis. ACS omega 6 (39) (2021)
Riham O Bakr, Mohammed Farrag El-Behairy, Ahmed M Elissawy, Hanan Elimam, Marwa A A Fayed
New Adenosine Derivatives from Aizoon canariense L.: In Vitro Anticholinesterase, Antimicrobial, and Cytotoxic Evaluation of Its Extracts. Molecules (Basel, Switzerland) 26 (5) (2021)
Hend Mohamed Abdel-Bar, Inas A Abdallah, Marwa A A Fayed, Yassmin Moatasim, Ahmed Mostafa, Mohammed Farrag El-Behairy, Hanan Elimam, Yaseen A M M Elshaier, Khaled A M Abouzid
Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies. RSC advances 11 (46) (2021)
Rasha M Ahmed, Marwa A A Fayed, Mohammed Farrag El-Behairy, Inas A Abdallah
Identification, isolation, structural characterization, in silico toxicity prediction and in vitro cytotoxicity assay of simeprevir acidic and oxidative degradation products. RSC advances 10 (70) (2020)